Drug name - Probuphine

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7736665 TITAN PHARMS Implantable polymeric device for sustained release of buprenorphine Apr, 2024

(1 year, 6 months from now)

Drugs and Companies using BUPRENORPHINE HYDROCHLORIDE ingredient

Treatment: For opioid dependence

Dosage: IMPLANT;IMPLANTATION

More Information on Dosage
Strength Dosage Availability
EQ 80MG BASE/IMPLANT IMPLANT;IMPLANTATION Discontinued

availability in other generic markets.

Click on the highlighted region to filter.